SYSMHC00061 |
SYSMHC00061_F0830_THP1_w632_P |
F20180830_KP_THP1_w632_P8.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class I |
HLA-A02:01,HLA-B27:05,HLA-B15:11,HLA-C03:03 |
32387766 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
RP-HPLC |
no |
DDA |
HCD |
|
|
|
1 |
SYSMHC00061 |
SYSMHC00061_F0830_THP1_w632_P |
F20180830_KP_THP1_w632_P7.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class I |
HLA-A02:01,HLA-B27:05,HLA-B15:11,HLA-C03:03 |
32387766 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
RP-HPLC |
no |
DDA |
HCD |
|
|
|
2 |
SYSMHC00061 |
SYSMHC00061_F0830_THP1_w632_P |
F20180830_KP_THP1_w632_P9.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class I |
HLA-A02:01,HLA-B27:05,HLA-B15:11,HLA-C03:03 |
32387766 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
RP-HPLC |
no |
DDA |
HCD |
|
|
|
3 |
SYSMHC00061 |
SYSMHC00061_F0830_THP1_w632_P |
F20180830_KP_THP1_w632_P6.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class I |
HLA-A02:01,HLA-B27:05,HLA-B15:11,HLA-C03:03 |
32387766 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
RP-HPLC |
no |
DDA |
HCD |
|
|
|
4 |
SYSMHC00061 |
SYSMHC00061_F0830_THP1_w632_P |
F20180830_KP_THP1_w632_P5.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class I |
HLA-A02:01,HLA-B27:05,HLA-B15:11,HLA-C03:03 |
32387766 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
RP-HPLC |
no |
DDA |
HCD |
|
|
|
5 |
SYSMHC00061 |
SYSMHC00061_F0830_THP1_w632_P |
F20180830_KP_THP1_w632_P2.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class I |
HLA-A02:01,HLA-B27:05,HLA-B15:11,HLA-C03:03 |
32387766 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
RP-HPLC |
no |
DDA |
HCD |
|
|
|
6 |
SYSMHC00061 |
SYSMHC00061_F0830_THP1_w632_P |
F20180830_KP_THP1_w632_P3.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class I |
HLA-A02:01,HLA-B27:05,HLA-B15:11,HLA-C03:03 |
32387766 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
RP-HPLC |
no |
DDA |
HCD |
|
|
|
7 |
SYSMHC00061 |
SYSMHC00061_F0830_THP1_w632_P |
F20180830_KP_THP1_w632_P10.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class I |
HLA-A02:01,HLA-B27:05,HLA-B15:11,HLA-C03:03 |
32387766 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
RP-HPLC |
no |
DDA |
HCD |
|
|
|
8 |
SYSMHC00061 |
SYSMHC00061_F0830_THP1_w632_P |
F20180830_KP_THP1_w632_P1.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class I |
HLA-A02:01,HLA-B27:05,HLA-B15:11,HLA-C03:03 |
32387766 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
RP-HPLC |
no |
DDA |
HCD |
|
|
|
9 |
SYSMHC00061 |
SYSMHC00061_F0830_THP1_w632_P |
F20180830_KP_THP1_w632_P4.raw |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
EBV transformed |
class I |
HLA-A02:01,HLA-B27:05,HLA-B15:11,HLA-C03:03 |
32387766 |
native |
Immunoaffinity |
W6/32 |
Orbitrap Fusion Lumos |
RP-HPLC |
no |
DDA |
HCD |
|
|
|
10 |